Previous 10 | Next 10 |
NRGene’s Genomics Platform to Accelerate Calyxt’s Trait Discovery in Hemp Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, today announced a research collaboration with NRGene ® that includes the adoption of NRGene’s cloud-base...
Calyxt, Inc. (CLXT) Q3 2020 Results Earnings Conference Call November 5, 2020, 4:30 PM ET Company Participants Chris Tyson - Senior Managing Director, MZ North America, IR Jim Blome - Chief Executive Officer Bill Koschak - Chief Financial Officer Conference Call Participants Bobby Burleson - ...
The following slide deck was published by Calyxt, Inc. in conjunction with their 2020 Q3 earnings call. For further details see: Calyxt, Inc. 2020 Q3 - Results - Earnings Call Presentation
Calyxt (CLXT): Q3 Non-GAAP EPS of -$0.28 beats by $0.02; GAAP EPS of -$0.29 beats by $0.01.Revenue of $5.24M (+76.4% Y/Y) beats by $0.87M.Press Release For further details see: Calyxt EPS beats by $0.02, beats on revenue
Execution of Commercial Agreement with S&W Seed Company on IQ™ Alfalfa Product, Marking Calyxt’s First Trait License Agreement Significant Progress Achieved on Soybean Product Transition Plan Third Quarter 2020 Revenue Increases 77% to $5.2 Million Year-On-Year...
S&W Seed Company Announces Commercial Agreement with Calyxt Inc. to Deliver Improved Quality Alfalfa S&W Seed Company Announces Commercial Agreement with Calyxt Inc. to Deliver Improved Quality Alfalfa PR Newswire LONGMONT, Colo., Nov. 2, 2020 LONGMONT,...
Point Roberts, WA and Delta, BC - October 30, 2020 (Investorideas.com Newswire) Investorideas.com , a global news source and leading retail investor and trader resource, announces its weekly roundup of stocks to watch. Today's stocks in Plant-Based, Mining, Nanotech, Sports and Psychede...
Agreement has the Potential to Generate More Than $10 Million of License Revenue from U.S. Sales Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, announced today that it has agreed to commercial terms with S&W Seed Company (Nasdaq: SANW ), a global ...
Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, will host a Virtual Analyst Day on Tuesday, November 17, 2020 at 4:00 p.m. Eastern time. The Virtual Analyst Day will be broadcasted via webcast, and include a review of the company’s research and development ...
Calyxt, Inc. (NASDAQ: CLXT) (the “Company”), a plant-based technology company, today announced the closing of its previously announced registered direct offering of 3,750,000 shares of the Company’s common stock, at a purchase price of $4.00 per share. Cellectis...
News, Short Squeeze, Breakout and More Instantly...
Shares of Calyxt, Inc. (NASDAQ: CLXT) traded at a new 52-week high today and are currently trading at $5.4. So far today, approximately 55,181 shares have been exchanged, as compared to an average 30-day volume of 89,248 shares. Calyxt, Inc., a synthetic biology company, engages in delivering...
Calyxt Announces Stockholder Approval of Merger With Cibus PR Newswire -- Calyxt Announces 1-for-5 Reverse Stock Split of Common Stock -- ROSEVILLE, Minn. , May 19, 2023 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT) ("Calyxt" or the "Company") today announc...
Calyxt Reports First Quarter 2023 Financial Results and Provides Corporate Update PR Newswire —P roposed merger with Cibus Global Expected to Close in Q2 2023 — —1-for-10 reverse stock split executed— —Current customer...